SCHEMBL8428280

SCHEMBL8428280

COc1ccc(F)c(-c2c[nH]c(=O)cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.49
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
DHODH Q02127 1/20 0.43
PDGFRB P09619 1/20 0.42
PIM1 P11309 1/20 0.41
GRK6 P43250 1/20 0.39
PTGES O14684 1/20 0.38
ALDH1A1 P00352 1/20 0.37
DYRK1A Q13627 1/20 0.36
FFAR1 O14842 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
POLQ O75417 1/20 0.36
STIM1 Q13586 1/20 0.36
ORAI1 Q96D31 1/20 0.36
METAP2 P50579 1/20 0.36
PDE2A O00408 1/20 0.36
PDE6D O43924 1/20 0.36
PDE6A P16499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277812 0.76 NPC1 (0.53) NPC1RAB9APDGFRBALDH1A1DYRK1A
SCHEMBL8430167 0.72 KDM1A (0.55) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL27322683 0.71 CCR1 (0.63) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL2403919 0.71 KDM1A (0.50) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL2403768 0.70 KDM1A (0.53) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL20341731 0.69 KDM1A (0.52) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL15990505 0.69 KDM1A (0.55) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL15990506 0.69 KDM1A (0.49) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL8430229 0.69 KDM1A (0.52) KDM1ANPC1RAB9ADHODHPIM1
SCHEMBL20924207 0.69 KDM1A (0.71) KDM1ANPC1RAB9ADHODHPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5910590-A INTERACTS WITH GABA BINDING SITE (THE BENZODIAZEPINE RECEPTOR); TREATMENT OF ANXIETY, SEIZURE AND SLEEP DISORDERS, ENHANCES ALERTNESS AND TREATMENT OF BENZODIAZEPINE OVERDOSES NEUROGEN CORPORATION (US) 1999-06-08 US disclosed
US-5668283-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1997-09-16 US disclosed
US-5606059-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE TYPE DRUGS AND THE ENHANCEMENT OF ALERTNESS NEUROGEN CORPORATION (US) 1997-02-25 US disclosed
WO-1994011374-A1 CERTAIN ARYL SUBSTITUTED PYRROLOPYRAZINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-05-26 WO disclosed
US-5286860-A Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1994-02-15 US disclosed